Roivant Sciences Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	124.8	124.8	61.28	55.29	23.8	67.69
Revenue Growth (YoY)	103.65%	103.65%	10.84%	132.34%	-64.85%	-
Cost of Revenue	15.56	15.56	13.13	8.97	2.06	1.13
Gross Profit	109.24	109.24	48.15	46.32	21.74	66.56
Selling, General & Admin	687.44	687.44	600.51	775.03	259.88	335.77
Research & Development	528.19	528.19	622.96	622.93	832.76	263.22
Other Operating Expenses	-5,348.41	-5,348.41	0	0	0	0
Operating Expenses	-4,132.78	-4,132.78	1,223	1,398	1,093	598.98
Operating Income	4,242	4,242	-1,175.32	-1,351.64	-1,070.9	-532.43
Interest Expense / Income	34.78	34.78	27.97	7.04	0	0
Other Expense / Income	-163.91	-163.91	-199.45	-513.79	-263.35	-1,740.06
Pretax Income	4,371	4,371	-1,003.84	-844.89	-807.55	1,208
Income Tax	22.22	22.22	5.19	0.37	1.69	7.12
Net Income	4,349	4,349	-1,009.03	-845.26	-809.23	1,201
Shares Outstanding (Basic)	783	783	713	670	630	219
Shares Outstanding (Diluted)	831	831	713	670	630	219
Shares Change	16.59%	16.59%	6.43%	6.30%	187.64%	-
EPS (Basic)	5.55	5.55	-1.42	-1.26	-1.28	5.13
EPS (Diluted)	5.23	5.23	-1.42	-1.26	-1.28	5.13
Free Cash Flow	-766.65	-766.65	-856.08	-695.17	-557.94	-763.67
Free Cash Flow Per Share	-0.98	-0.98	-1.20	-1.04	-0.89	-3.49
Gross Margin	87.53%	87.53%	78.58%	83.78%	91.36%	98.33%
Operating Margin	3399.19%	3399.19%	-1917.95%	-2444.82%	-4500.52%	-786.58%
Profit Margin	3484.86%	3484.86%	-1646.59%	-1528.89%	-3400.86%	1773.57%
Free Cash Flow Margin	-614.33%	-614.33%	-1397.00%	-1257.40%	-2344.80%	-1128.20%
Effective Tax Rate	0.51%	0.51%	-	-	-	0.59%
EBITDA	4,435	4,435	-949.45	-824.65	-807.55	1,208
EBITDA Margin	3553.68%	3553.68%	-1549.36%	-1491.61%	-3393.77%	1784.09%
Depreciation & Amortization	28.88	28.88	26.42	13.2	0	0
EBIT	4,406	4,406	-975.87	-837.85	-807.55	1,208
EBIT Margin	3530.53%	3530.53%	-1592.48%	-1515.49%	-3393.77%	1784.09%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).